Projected Growth of the Global Drug Formulation Market to Reach $2894.29 Billion by 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the drug formulation market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Drug Formulation Market By The End Of 2029?

The drug formulation market has witnessed robust growth in recent years. Its size is expected to escalate from $1908.89 billion in 2024 to $2045.31 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.1%. This historical expansion can be attributed to factors such as biopharmaceutical innovation, patient-centric drug development, the emergence of personalized medicine, strong regulatory support for orphan drugs, and heightened R&D investment.

The drug formulation market is projected to experience substantial expansion in the coming years, with its size forecasted to reach $2894.29 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.1%. During the forecast period, this growth is largely driven by progress in 3D printing, an increased emphasis on pediatric formulations, the development of biological drug delivery systems, the adoption of green chemistry in formulation, and the incorporation of artificial intelligence (AI). Key trends anticipated in the upcoming period encompass the dominance of biopharmaceuticals and biologics, sophisticated drug delivery systems, personalized medicine and tailored formulations, the integration of nanotechnology, and strategies for lifecycle management and reformulation.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9900&type=smp

Which Business Drivers Are Underpinning The Growth Of The Drug Formulation Market?

The increasing occurrence of chronic diseases is anticipated to fuel the expansion of the drug formulation market moving forward. Chronic diseases are conditions defined as persisting for a year or longer, necessitating continuous medical care, restricting daily life activities, or both. Drug formulation possesses the ability to reduce the incidence of chronic illnesses by employing various drug delivery techniques to maximize therapeutic effectiveness while simultaneously minimizing negative side effects, achieved by impacting medication absorption, distribution, metabolism, and excretion. For example, a report from September 2022, published by the National Institutes of Health (NIH), a US-based biomedical research agency, projects that in 2023, in the United States, the population aged 50 and above with at least one chronic illness will surge by 99.5%, escalating from 71.52 million in 2020 to 142.66 million in 2050. Furthermore, the count of individuals experiencing multimorbidity is expected to climb by 91.16%, from 7.8304 million in 2020 to 14.968 million in 2050. Consequently, the increasing occurrence of chronic diseases is a primary factor propelling the expansion of the drug formulation market.

What Are The Principal Segment Types In The Drug Formulation Market?

The drug formulation market covered in this report is segmented –

1) By Dosage Form: Oral formulations, Parenteral Formulations, Topical Formulations, Inhalation Formulations

2) By Formulation: Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other Formulations

3) By Therapy Area: Cardiovascular Diseases (CVDs), Pain, Diabetes, Cancer, Respiratory Diseases, Other Diseases

4) By End-User: Big Pharma, Small And Medium Pharma, Biotech Companies

Subsegments:

1) By Oral Formulations: Tablets, Capsules, Powders, Liquids Or Solutions

2) By Parenteral Formulations: Injectables, Implants, Infusions

3) By Topical Formulations: Creams, Ointments, Gels, Transdermal Patches

4) By Inhalation Formulations: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

How Are Industry Trends Steering The Expansion Of The Drug Formulation Market?

Technological advancements are emerging as a significant trend in the drug formulation market. Major participants in this sector are focusing on introducing new and sophisticated technologies to enhance their standing in the market. As an illustration, in June 2022, Merck & Co., Inc., a pharmaceutical company based in the US, launched the Merck Digital Sciences Studio (MDSS) to enable the development of innovative technologies for drug research and development. Merck employs Azure Cloud’s robust computing resources and the expertise of its discovery and clinical professionals to collaboratively accelerate and integrate novel digital technologies. MDSS is a partnership between Merck and the New Jersey Innovation Institute (NJII), a US-based entity owned by the New Jersey Institute of Technology. The Merck Global Health Innovation Fund, Northpond Ventures, and McKesson Ventures have all contributed investments to this initiative. Furthermore, Microsoft will extend technology support to start-up companies involved in the project.

Which Companies Are Contributing Significantly To The Drug Formulation Market Growth?

Major companies operating in the drug formulation market include AstraZeneca PLC, The Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., AbbVie Inc., C.H. Boehringer Sohn AG & Co. KG, F. Hoffmann-La Roche AG, Johnson & Johnson, Bayer AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A., GlaxoSmithKline plc, Novo Nordisk A/S, Amgen Inc., Viatris Inc., Sandoz International GmbH, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Limited, Torrent Pharmaceuticals Limited, Jubilant Life Sciences Limited, Cadila Healthcare Limited, Glenmark Pharmaceuticals Ltd., Wockhardt Ltd., Hikma Pharmaceuticals plc

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/drug-formulation-global-market-report

Which Region Offers The Most Opportunity For Drug Formulation Market Expansion?

North America was the largest region in the drug formulation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug formulation market report during the forecast period. The regions covered in the drug formulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=9900&type=smp

Browse Through More Reports Similar to the Global Drug Formulation Market 2025, By The Business Research Company

Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Drugs For Immunotherapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Drugs For Hormonal Replacement Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-hormonal-replacement-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795